
Vertex Newly Approved Pain Treatment Lands Higher Cost Tier 3 Placement In UnitedHealth's Optum Rx Formularies
In January, the Food and Drug Administration (FDA) approved Vertex Pharmaceuticals Inc. VRTX Journavx, a non-opioid oral pain signal inhibitor for acute pain. This marked the first approval of a new class of pain medication in more than 20 years, offering …